Adma Biologics (ADMA) Intangibles (2017 - 2025)
Adma Biologics (ADMA) reported Intangibles of $632000.0 for Q4 2025, up 37.39% on a YoY basis from $460000.0 in Q4 2024, and up 28.72% quarter-over-quarter from $491000.0 in Q3 2025.
Adma Biologics (ADMA) Intangibles (2017 - 2025) Analysis & Trends
Adma Biologics has reported Intangibles for 9 years, with the latest figure at $632000.0 in Q4 2025.
- For the quarter ending Q4 2025, Intangibles rose 37.39% year-over-year to $632000.0; the trailing twelve-month figure through Dec 2025 stood at $632000.0 (up 37.39% YoY), and the FY2025 full-year result was $632000.0, up 37.39% from the prior year.
- Intangibles for Q4 2025 stood at $632000.0, up from $491000.0 in the prior quarter.
- The five-year high for Intangibles was $6.1 million in Q2 2021, with the low at $321000.0 in Q1 2024.
- Historically, Intangibles has averaged $1.9 million across 5 years, with a median of $923788.5 in 2022.
- Annual changes were most pronounced in 2024 — Intangibles surged 1067.12% — and 2025, when it plunged 91.18%.
- Adma Biologics' Intangibles stood at $1.7 million in 2021, then sank by 41.4% to $1.0 million in 2022, then plunged by 50.74% to $499000.0 in 2023, then slipped by 7.82% to $460000.0 in 2024, then jumped by 37.39% to $632000.0 in 2025.
- The last three Intangibles figures came in at $632000.0 (Q4 2025), $491000.0 (Q3 2025), and $527000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 460,000.00 |
| Sep 30, 2024 | 5.57 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 499,000.00 |
| Sep 30, 2023 | 476,902.00 |
| Jun 30, 2023 | 655,740.00 |
| Mar 31, 2023 | 834,577.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 6.08 Mn |
| Jun 30, 2021 | 6.08 Mn |
| Mar 31, 2021 | 2.27 Mn |